West Pharmaceutical Services Past Earnings Performance
Past criteria checks 4/6
West Pharmaceutical Services has been growing earnings at an average annual rate of 22.1%, while the Life Sciences industry saw earnings growing at 16.4% annually. Revenues have been growing at an average rate of 12.7% per year. West Pharmaceutical Services's return on equity is 20.6%, and it has net margins of 20.1%.
Key information
22.1%
Earnings growth rate
22.0%
EPS growth rate
Life Sciences Industry Growth | 21.5% |
Revenue growth rate | 12.7% |
Return on equity | 20.6% |
Net Margin | 20.1% |
Next Earnings Update | 25 Apr 2024 |
Recent past performance updates
Recent updates
West Pharmaceutical Services, Inc.'s (NYSE:WST) Business Is Yet to Catch Up With Its Share Price
Mar 30Is West Pharmaceutical Services (NYSE:WST) A Risky Investment?
Mar 12Why West Pharma Is Far From Done
Feb 28West Pharmaceutical Services, Inc.'s (NYSE:WST) Intrinsic Value Is Potentially 19% Below Its Share Price
Feb 20West Pharmaceutical Services: Still Too Expensive After The Recent Drop
Feb 20What Does West Pharmaceutical Services, Inc.'s (NYSE:WST) Share Price Indicate?
Jan 10West Pharmaceutical: Great Business, Not So Great Valuation
Jan 08What West Pharmaceutical Services, Inc.'s (NYSE:WST) P/E Is Not Telling You
Dec 18West Pharmaceutical Services (NYSE:WST) Has A Pretty Healthy Balance Sheet
Nov 27West Pharmaceutical Services: The Run Might Be Over
Oct 18Is West Pharmaceutical Services, Inc. (NYSE:WST) Potentially Undervalued?
Sep 24Is West Pharmaceutical Services (NYSE:WST) Using Too Much Debt?
Aug 22West Pharmaceutical: Revise To Buy On Exceptional Economic Characteristics
Aug 08What Is West Pharmaceutical Services, Inc.'s (NYSE:WST) Share Price Doing?
Jun 26West Pharmaceutical: Hard To Justify The Price
May 26Is West Pharmaceutical Services (NYSE:WST) Using Too Much Debt?
May 16At US$330, Is It Time To Put West Pharmaceutical Services, Inc. (NYSE:WST) On Your Watch List?
Mar 20West Pharmaceutical Services' (NYSE:WST) Soft Earnings Don't Show The Whole Picture
Feb 28West Pharmaceutical Q4 2022 Earnings Preview
Feb 15West Pharmaceutical Services (NYSE:WST) Has A Pretty Healthy Balance Sheet
Jan 31West Pharmaceutical: An Earnings Decline Seen In 2023, Shares Still Appear Expensive
Dec 19West Pharmaceutical declares $0.19 dividend
Dec 13Why West Pharmaceutical Services, Inc. (NYSE:WST) Could Be Worth Watching
Nov 29West Pharmaceutical Q3 2022 Earnings Preview
Oct 26West Pharmaceutical Services (NYSE:WST) Seems To Use Debt Rather Sparingly
Oct 25West Pharmaceutical Services: Shares Need To Get Cheaper To Make Sense
Oct 02Is West Pharmaceutical Services, Inc. (NYSE:WST) Expensive For A Reason? A Look At Its Intrinsic Value
Sep 14Is There Now An Opportunity In West Pharmaceutical Services, Inc. (NYSE:WST)?
Aug 31Do West Pharmaceutical Services' (NYSE:WST) Earnings Warrant Your Attention?
Aug 18West Pharmaceutical Q2 Non-GAAP EPS, revenue beats
Jul 28Is West Pharmaceutical Services (NYSE:WST) Using Too Much Debt?
Jul 27West Pharmaceutical Services: A Great Business At A Lofty Price
Jul 06West Pharmaceutical Services, Inc. (NYSE:WST) Shares Could Be 32% Above Their Intrinsic Value Estimate
Jun 09Should You Think About Buying West Pharmaceutical Services, Inc. (NYSE:WST) Now?
May 20Does West Pharmaceutical Services (NYSE:WST) Deserve A Spot On Your Watchlist?
May 05Healthy Dividends: Organic Growth Points North For West Pharmaceutical Services
Apr 27We Think West Pharmaceutical Services (NYSE:WST) Can Manage Its Debt With Ease
Apr 22Revenue & Expenses BreakdownBeta
How West Pharmaceutical Services makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 2,950 | 593 | 354 | 68 |
30 Sep 23 | 2,927 | 559 | 299 | 66 |
30 Jun 23 | 2,866 | 519 | 326 | 63 |
31 Mar 23 | 2,884 | 552 | 319 | 61 |
31 Dec 22 | 2,887 | 586 | 316 | 59 |
30 Sep 22 | 2,909 | 631 | 377 | 56 |
30 Jun 22 | 2,929 | 686 | 352 | 56 |
31 Mar 22 | 2,881 | 684 | 362 | 55 |
31 Dec 21 | 2,832 | 662 | 356 | 53 |
30 Sep 21 | 2,681 | 613 | 340 | 52 |
30 Jun 21 | 2,523 | 519 | 310 | 51 |
31 Mar 21 | 2,326 | 423 | 308 | 48 |
31 Dec 20 | 2,147 | 346 | 301 | 47 |
30 Sep 20 | 2,037 | 312 | 291 | 44 |
30 Jun 20 | 1,945 | 286 | 297 | 41 |
31 Mar 20 | 1,888 | 261 | 277 | 40 |
31 Dec 19 | 1,840 | 242 | 273 | 39 |
30 Sep 19 | 1,792 | 230 | 262 | 39 |
30 Jun 19 | 1,767 | 229 | 259 | 39 |
31 Mar 19 | 1,745 | 219 | 258 | 41 |
31 Dec 18 | 1,717 | 207 | 256 | 40 |
30 Sep 18 | 1,711 | 155 | 257 | 40 |
30 Jun 18 | 1,677 | 151 | 256 | 39 |
31 Mar 18 | 1,627 | 133 | 248 | 38 |
31 Dec 17 | 1,599 | 151 | 243 | 39 |
30 Sep 17 | 1,566 | 190 | 245 | 39 |
30 Jun 17 | 1,544 | 176 | 242 | 39 |
31 Mar 17 | 1,535 | 182 | 243 | 38 |
31 Dec 16 | 1,509 | 144 | 238 | 37 |
30 Sep 16 | 1,487 | 138 | 241 | 37 |
30 Jun 16 | 1,454 | 102 | 238 | 37 |
31 Mar 16 | 1,426 | 85 | 246 | 36 |
31 Dec 15 | 1,400 | 96 | 243 | 34 |
30 Sep 15 | 1,390 | 94 | 240 | 32 |
30 Jun 15 | 1,401 | 123 | 241 | 33 |
31 Mar 15 | 1,411 | 133 | 228 | 35 |
31 Dec 14 | 1,421 | 127 | 229 | 37 |
30 Sep 14 | 1,414 | 119 | 230 | 39 |
30 Jun 14 | 1,400 | 115 | 230 | 39 |
31 Mar 14 | 1,376 | 108 | 232 | 39 |
31 Dec 13 | 1,368 | 112 | 235 | 38 |
30 Sep 13 | 1,347 | 110 | 234 | 37 |
30 Jun 13 | 1,309 | 98 | 231 | 35 |
Quality Earnings: WST has high quality earnings.
Growing Profit Margin: WST's current net profit margins (20.1%) are lower than last year (20.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: WST's earnings have grown significantly by 22.1% per year over the past 5 years.
Accelerating Growth: WST's earnings growth over the past year (1.3%) is below its 5-year average (22.1% per year).
Earnings vs Industry: WST earnings growth over the past year (1.3%) exceeded the Life Sciences industry -9.3%.
Return on Equity
High ROE: WST's Return on Equity (20.6%) is considered high.